Trials / Conditions / PTEN Hamartoma Tumor Syndrome

PTEN Hamartoma Tumor Syndrome

9 registered clinical trials studyying PTEN Hamartoma Tumor Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations NCT07218575	Boston Children's Hospital	Phase 2 / Phase 3
Withdrawn	Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations NCT06080165	Stanford University	Phase 1 / Phase 2
Recruiting	PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry NCT06462430	Yale University	—
Completed	Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients NCT05671107	John Carroll University	—
Completed	Sirolimus for Cowden Syndrome With Colon Polyposis NCT04094675	Ohio State University	Phase 2
Unknown	Response of Immune System to Flu Vaccination in PHTS NCT03630523	Radboud University Medical Center	N/A
Completed	RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome NCT02991807	Boston Children's Hospital	Phase 1 / Phase 2
Recruiting	Familial Investigations of Childhood Cancer Predisposition NCT03050268	St. Jude Children's Research Hospital	—
Recruiting	Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations NCT02461446	Boston Children's Hospital	—